{"id":26791,"date":"2023-12-14T08:10:23","date_gmt":"2023-12-14T13:10:23","guid":{"rendered":"https:\/\/worldjusticenews.com\/news\/?p=26791"},"modified":"2023-12-14T08:10:23","modified_gmt":"2023-12-14T13:10:23","slug":"us-supreme-court-to-consider-abortion-pill-case","status":"publish","type":"post","link":"https:\/\/worldjusticenews.com\/news\/2023\/12\/14\/us-supreme-court-to-consider-abortion-pill-case\/","title":{"rendered":"US Supreme Court to consider abortion pill case"},"content":{"rendered":"
\n
\n

The US Supreme Court will decide whether to restrict access to a commonly used abortion pill.<\/b><\/p>\n<\/div>\n<\/div>\n

\n
\n

It will be the most significant US reproductive rights case after the court overturned Roe v Wade, ending a nationwide right to abortion.<\/p>\n<\/div>\n<\/div>\n

\n
\n

The Biden administration had asked the court to overturn a decision to limit access to the drug mifepristone over anti-abortion groups’ safety concerns.<\/p>\n<\/div>\n<\/div>\n

\n
\n

The pill has been legal in the US since 2000 and research has shown it is safe.<\/p>\n<\/div>\n<\/div>\n

\n
\n

The Supreme Court, which has a 6-3 conservative majority, will hear arguments early next year. A ruling is expected next summer, months before the next presidential election.<\/p>\n<\/div>\n<\/div>\n

\n
\n

This current clash over access began in November 2022, when an umbrella group of anti-abortion doctors and activists known as the Alliance for Hippocratic Medicine sued in Texas. They claimed the Food and Drug Administration (FDA) had unlawfully approved the drug and alleged the pill was unsafe.<\/p>\n<\/div>\n<\/div>\n

\n
\n

The case puts the court back in the position to decide American reproductive rights, less than two years after overturning Roe v Wade – a landmark 1973 ruling that guaranteed abortion access in the US.<\/p>\n<\/div>\n<\/div>\n

\n
\n

Since the court nixed the decades-old decision, nearly two dozen states have moved to ban or restrict abortion procedures. Other states have moved to expand access by adding legal safeguards.<\/p>\n<\/div>\n<\/div>\n

\n
\n

More recently, that battle over abortion has centred on medication abortions, now the most common method of ending pregnancies in the US, according to the Guttmacher Institute, a pro-abortion research group.<\/p>\n<\/div>\n<\/div>\n

\n
\n

The two drug-regimen was approved for use up to 10 weeks of pregnancy by the FDA in 2000. When used, a patient is first given mifepristone to induce an abortion and then misoprostol to empty the uterus.<\/p>\n<\/div>\n<\/div>\n

\n
\n

Since 2016, the FDA has further eased access to the drug. The agency has allowed doctors to meet patients via telemedicine and prescriptions to be sent by mail.<\/p>\n<\/div>\n<\/div>\n

\n
\n
\n